Meet the Start-ups

Maria van Dongen | CEO & Co-Founder | Allegria Therapeutics

Maria van Dongen, PhD, is CEO and co-founder of Allegria Therapeutics. She describes herself as an accountable and strategic R&D leader with a passion to unlock cutting-edge scientific innovation to progress drug discovery programs to clinical development, enhance patient outcomes and increase business value. Maria brings 25+ years of experience in pharmaceutical and biotech R&D, across a variety of therapeutic modalities and therapeutic areas. Her proficiency as a CEO is furthermore based on a strong experience in strategic partnering and an ongoing MSc education in business valuation.

Allegria Therapeutics

Allegria Therapeutics is a Basel-based biopharma startup established in 2023 with a commitment to build a differentiated portfolio of therapeutic approaches around biological targets that modulate mast cells as drivers of allergy and inflammatory disease. We focus our efforts on sustainable innovation to address significant unmet medical need and drive long-term growth.